Inventor · disambiguated record
Bindu Varghese
Also filed as: VARGHESE BINDU
13 granted patents·7 pending applications·123 citations·filing 2004–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0198US9462794B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2015·Granted Oct 11, 2016·28 cites·41 claims
- 0298US9193977B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2014·Granted Nov 24, 2015·29 cites·28 claims
- 0398US9127292B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2014·Granted Sep 8, 2015·28 cites·16 claims
- 0497US9901083B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2017·Granted Feb 27, 2018·8 cites·20 claims
- 0596US11019810B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2019·Granted Jun 1, 2021·6 cites·14 claims
- 0694US12054557B2Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancerREGENERON PHARMA·Filed 2021·Granted Aug 6, 2024·4 cites·33 claims
- 0794US10206379B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2018·Granted Feb 19, 2019·4 cites·18 claims
- 0893US10550193B2Methods and antibody compositions for tumor treatmentREGENERON PHARMA·Filed 2015·Granted Feb 4, 2020·8 cites·32 claims
- 0989US10426146B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2019·Granted Oct 1, 2019·2 cites·9 claims
- 1082US11434300B2Methods and antibody compositions for tumor treatmentREGENERON PHARMA·Filed 2019·Granted Sep 6, 2022·2 cites·20 claims
- 1179US12161097B2Non-human animals having a humanized signal-regulatory protein geneREGENERON PHARMA·Filed 2021·Granted Dec 10, 2024·0 cites·7 claims
- 1279US10662244B2Methods for tumor treatment using CD3XCD20 bispecific antibodyREGENERON PHARMA·Filed 2015·Granted May 26, 2020·2 cites·17 claims
- 1377US8961926B2Method of imaging localized infectionsLOW PHILIP STEWART·Filed 2008·Granted Feb 24, 2015·2 cites·19 claims
- 1474US2023220101A1Methods and Antibody Compositions for Tumor TreatmentREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1565US2024218070A1FAP BINDING DOMAINS AND BISPECIFIC BINDING MOIETIES THAT BIND FAP AND TGF-ßRIIMERUS NV·Filed 2023·Application pending·0 cites
- 1662US2023250190A1Binding domains against cancer-associated muc1MERUS NV·Filed 2022·Application pending·0 cites
- 1756US2008119475A1Conjugates And Use ThereofLOW PHILIP STEWART·Filed 2007·Application pending·0 cites
- 1851US2006204565A1Conjugates and use thereofLOW PHILIP S·Filed 2004·Application pending·0 cites
- 1945US2017174779A1Combination of Anti-PD-1 Antibodies and Anti-CD20/Anti-CD3 Antibodies to Treat CancerREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 2045US2007276231A1Positron Emission Tomography Imaging MethodLOW PHILIP S·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →